CIK: 0001732811 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 13, 2020
Total Value ($000): $485,272 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOXA | FOX CORP | 2,369,331 | $87,831 | 18.1% | $35.41 | -10.8% | CL A COM | 35137L105 |
| — | LIBERTY GLOBAL PLC | 4,000,040 | $87,181 | 18.0% | $23.72 | — | SHS CL C | G5480U120 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 6,439,541 | $85,710 | 17.7% | $11.07 | -0.4% | COM CL A | 46333X108 |
| LNG | CHENIERE ENERGY INC | 1,050,000 | $64,124 | 13.2% | $62.26 | -1.1% | COM NEW | 16411R208 |
| XPO | XPO LOGISTICS INC | 700,000 | $55,790 | 11.5% | $27.03 | +1.7% | COM | 983793100 |
| — | PIONEER NAT RES CO | 263,500 | $39,886 | 8.2% | $130.13 | — | COM | 723787107 |
| PCG | PG&E CORP | 3,554,299 | $38,635 | 8.0% | $18.43 | -54.0% | COM | 69331C108 |
| — | GTT COMMUNICATIONS INC | 1,149,596 | $13,048 | 2.7% | $20.82 | — | COM | 362393100 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,000,000 | $7,560 | 1.6% | $4.90 | -66.2% | COM | 00461U105 |
| — | CYCLERION THERAPEUTICS INC | 1,487,874 | $4,047 | 0.8% | $11.45 | — | COM | 23255M105 |
| EOLS | EVOLUS INC | 120,000 | $1,460 | 0.3% | $19.82 | -28.9% | COM | 30052C107 |